naphthalimides has been researched along with Central Nervous System Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, TD; Craig, JB; Jaeckle, K; Rankin, C; Solank, DL; Taylor, SA; Townsend, JJ; Vance, RB | 1 |
1 trial(s) available for naphthalimides and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.
Topics: Adenine; Adult; Antineoplastic Agents; Central Nervous System Neoplasms; Drug Administration Schedule; Female; Humans; Imides; Infusions, Intravenous; Isoquinolines; Male; Naphthalimides; Organophosphonates | 2002 |